Form 4: Phreesia SVP David Linetsky Reports Stock Sales to Cover Tax Obligations
SEC Form 4
David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported selling shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On March 18, 2024, David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 46 shares of common stock at a weighted average price of $22.2162 per share.
- These sales were non-discretionary transactions to cover tax withholding obligations related to the settlement of restricted stock units.
- On March 19, 2024, Linetsky sold 402 shares of common stock at a weighted average price of $23.2733 per share.
- Following these transactions, Linetsky directly owns 204,059 shares of Phreesia common stock and indirectly owns 7,125 shares through his spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock sales for tax purposes, which is a routine activity.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax obligations. The disclosure provides transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Sale of 46 shares of common stock. |
| 03/19/2024 | Sale of 402 shares of common stock. |
| 03/20/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.